PFIZER4,092.00

Pfizer Ltd.

· Pharma & Health
₹ CrorePeersGLAXOABBOTINDIAPOLYMEDONESOURCERAINBOWKIMSJUBLPHARMAVIJAYA
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation62.360.857.7
+ Finance Costs15.48.49.5
+ Interest Income-132.5-157.3-165.7
Changes in Working Capital
+ Inventories-16.0-42.2-25.2
+ Trade Receivables — Current-36.5-6.89.1
+ Trade Payables — Current-50.2-15.363.3
Cash from Operating Activities
Profit Before Tax (per I/S)746.11,016.1975.71,252.4
Cash from Operations (pre-tax)410.7816.0953.0
+ Income Taxes Paid153.8156.214.5
Cash from Operating Activities256.8659.8967.6
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)18.928.225.2
+ Disp of Fixed Assets0.00.21.2
+ Interest Received — Investing128.8139.4177.0
Cash from Investing Activities53.7-71.3-561.7
Cash from Financing Activities
+ Payment of Lease Liabilities41.137.334.0
Cash from Financing Activities-235.1-205.3-798.3
Net Changes in Cash383.1
Closing Cash112.0495.1102.7
Reference Items
EBITDA635.3740.2904.11,151.7
EBITDA Margin %28.9732.4535.8836.30
Free Cash Flow (CFO − Capex)237.9631.6942.3942.3
Cash Flow to Net Income0.470.861.34
Cash Paid for Taxes153.8156.214.5
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.